NYSE:JNJ
Johnson & Johnson
Johnson & Johnson's revenue grew 6.0% in fiscal 2025 to $94.2B. Free cash flow was $19.7B, 20.9% of revenue.Summary generated from Johnson & Johnson's SEC filings. Latest annual report filed Feb 11, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$94.2B
Revenue growth+6.0%
Revenue, 5-yr CAGR+2.7%
Gross margin67.9%
Operating marginn/a
Net margin28.5%
ROICn/a
Return on equity35.0%
Debt / equity0.61
Free cash flow$19.7B
FCF margin20.9%
Share count change+0.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 78.7 | 80.0 | 85.2 | 88.8 | 94.2 |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | 20.9 | 17.9 | 35.2 | 14.1 | 26.8 |
| Free cash flow | 19.8 | 17.2 | 18.2 | 19.8 | 19.7 |
Recent filings
- 4Insider transaction report
Sep 10, 2026 - 4Insider transaction report
Sep 10, 2026 - 8-KDirector or officer change
Aug 4, 2026 - 8-KRegulation FD disclosure
Jul 29, 2026 - 8-KRegulation FD disclosure
Jul 28, 2026 - 10-QQuarterly report for the period ended Jun 28, 2026
Jul 23, 2026 - 8-KResults of operations and financial condition
Jul 15, 2026 - 8-KResults of a shareholder vote
Apr 28, 2026